NICOLINI GABRIELLA

Fermi, S., Malacrida, A., Molteni, L., Miloso, M., Cavaletti, G., Nicolini, G. (2025). Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation. Intervento presentato a: 2025 PNS Annual Meeting, Edinburgh, Scotland. Dettaglio

Molteni, L., Bragato, C., Persico, A., Nicolini, G., Re, F., Mantecca, P., et al. (2025). Targeted Paclitaxel Delivery Via Metalloproteinase-Sensitive Liposomes To Prevent Peripheral Neurotoxicity: A Proof Of Concept. Intervento presentato a: 2025 PERIPHERAL NERVE SOCIETY ANNUAL MEETING - 17-20 May 2025, Edimburgo, UK. Dettaglio

Molteni, L., Persico, A., Kravicz, M., Antoniou, A., Peqini, K., Mantecca, P., et al. (2025). REDUCING PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY VIA LIPOSOMAL DRUG TARGETING. In Proceedings of the 35th National Conference of the Italian Group for the Study of Neuromorphology “Gruppo Italiano per lo Studio della Neuromorfologia” G.I.S.N. (pp.25-25). Dettaglio

Silva, C., Zuliani, V., Nicolini, G., Malacrida, A., Rivara, M. (2025). Recent advances in the discovery of ALKBH 1–8 inhibitors. EXPERT OPINION ON DRUG DISCOVERY, 20(12), 1639-1654 [10.1080/17460441.2025.2582541]. Dettaglio

Sica, F., Patrucco, M., Giambra, M., Ghizzi, M., Sesana, S., Vergani, B., et al. (2025). Modulation of the blood–brain barrier permeability by patient-derived glioblastoma stem cell secretome. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-21272-3]. Dettaglio